×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Principal Investigator  
Principal Investigator's Name: M l
Institution: Chengdu University of Information Technology
Department: College of Electronic Engineering
Country:
Proposed Analysis: Alzheimer's Disease (AD), commonly known as Alzheimer's disease, is an irreversible and fatal chronic neurological disease. At present, there are 50 million people with Alzheimer's disease in the world, and the number of patients is increasing year by year. The disease develops slowly, and there is no clinical solution to completely cure the disease. Only in the prodromal stage of the disease (Mild Cognitive Impairment, MCI), some drugs or psychological interventions can be used to alleviate the symptoms and delay the disease. Therefore, it is very important to diagnose the disease and its prodromal stage through medical imaging technology, which has great clinical significance for the follow-up treatment of patients. Functional Magnetic Resonance Imaging (fMRI) technology has been introduced as a non-invasive, high-resolution neuroimaging technology, and has excellent performance in the diagnosis of Alzheimer's disease. With the continuous development of artificial intelligence, machine learning has become a major research hotspot. As a major branch of machine learning, deep learning is widely used in the field of medical images. Therefore, this paper combined fMRI images and a deep learning-based method to predict the three stages of Alzheimer's disease (AD, MCI, and Normal Congnize (NC)).
Additional Investigators